Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.61
-0.06 (-0.69%)
May 26, 2026, 4:00 PM EDT - Market closed
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $521.17 million as of May 27, 2026. Its market cap has increased by 471.51% in one year.
Market Cap
521.17M
Enterprise Value
318.47M
1-Year Change
471.51%
Ranking
Category
Stock Price
$8.61
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $521.17M, a decrease of -41.97%. That is a compound annual growth rate of -21.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 521.17M | -2.95% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 549.38M |
| Assembly Biosciences | 545.58M |
| MiMedx Group | 539.18M |
| Rigel Pharmaceuticals | 536.75M |
| Prime Medicine | 536.43M |
| ProKidney | 528.60M |
| Forte Biosciences | 527.57M |
| Climb Bio | 525.45M |